Literature DB >> 21036539

Applying a statistical PTB detection procedure to complement the gold standard.

Norliza Mohd Noor1, Ashari Yunus, S A R Abu Bakar, Amran Hussin, Omar Mohd Rijal.   

Abstract

This paper investigates a novel statistical discrimination procedure to detect PTB when the gold standard requirement is taken into consideration. Archived data were used to establish two groups of patients which are the control and test group. The control group was used to develop the statistical discrimination procedure using four vectors of wavelet coefficients as feature vectors for the detection of pulmonary tuberculosis (PTB), lung cancer (LC), and normal lung (NL). This discrimination procedure was investigated using the test group where the number of sputum positive and sputum negative cases that were correctly classified as PTB cases were noted. The proposed statistical discrimination method is able to detect PTB patients and LC with high true positive fraction. The method is also able to detect PTB patients that are sputum negative and therefore may be used as a complement to the gold standard.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21036539     DOI: 10.1016/j.compmedimag.2010.10.002

Source DB:  PubMed          Journal:  Comput Med Imaging Graph        ISSN: 0895-6111            Impact factor:   4.790


  2 in total

1.  A systematic review of the diagnostic accuracy of artificial intelligence-based computer programs to analyze chest x-rays for pulmonary tuberculosis.

Authors:  Miriam Harris; Amy Qi; Luke Jeagal; Nazi Torabi; Dick Menzies; Alexei Korobitsyn; Madhukar Pai; Ruvandhi R Nathavitharana; Faiz Ahmad Khan
Journal:  PLoS One       Date:  2019-09-03       Impact factor: 3.240

2.  Application of phase congruency for discriminating some lung diseases using chest radiograph.

Authors:  Omar Mohd Rijal; Hossein Ebrahimian; Norliza Mohd Noor; Amran Hussin; Ashari Yunus; Aziah Ahmad Mahayiddin
Journal:  Comput Math Methods Med       Date:  2015-03-31       Impact factor: 2.238

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.